Johansson 2006: The Karolinska Research That Found Biological Markers in People with EMF Sensitivity

Johansson 2006: The Karolinska Research That Found Biological Markers in People with EMF Sensitivity

Por Aires Tech

EMF Research File — The Landmark Studies

Johansson 2006: The Karolinska Research That Found Biological Markers in People Who Report EMF Sensitivity

Johansson O, 2006 — Pathophysiology — Karolinska Institute, Sweden

“Persons with self-reported sensitivity to electromagnetic fields have a significant alteration of the skin’s mast cell population and distribution.” — Johansson, 2006
Review paper: Electrohypersensitivity: State-of-the-art of a functional impairment
Author: Olle Johansson, PhD, Associate Professor, Karolinska Institute, Experimental Dermatology Unit, Department of Neuroscience
Journal: Pathophysiology, 2006
Type: Review with original skin biopsy data
Finding: People reporting electromagnetic hypersensitivity (EHS) show distinct biological differences in skin mast cell density and morphology compared to controls

The Question the Johansson Research Addresses

Electromagnetic hypersensitivity (EHS) — the experience of adverse symptoms attributed to electromagnetic field exposure — is one of the most contested topics in EMF research. The dominant medical-establishment position is that EHS is psychosomatic: that individuals believe they are sensitive but cannot detect EMF in blinded experiments, and therefore no real biological sensitivity exists.

Johansson’s contribution is different: rather than asking whether EHS individuals can detect EMF, he asked whether their bodies show objective biological differences. His answer, from skin biopsy data, is yes.

The Biological Marker Findings

Altered mast cell density and distribution. Skin biopsies from individuals reporting EHS showed significantly different mast cell populations compared to controls — both in number and in their distribution within the skin layers. Mast cells are immune cells involved in inflammatory responses and are known to respond to physical stressors including electromagnetic field exposure in animal models.
Elevated histamine-releasing cells. EHS subjects also showed elevated numbers of histamine-releasing cells in the skin — consistent with a chronic, low-level inflammatory response. Histamine release from mast cells causes vasodilation, increased vascular permeability, and the kind of skin symptoms (flushing, burning, tingling) that EHS individuals commonly report.
Nerve fiber changes. Some biopsies in EHS subjects showed changes in the density and morphology of cutaneous nerve fibers — again objectively distinct from controls. This is significant because it suggests that EHS may involve actual neurological changes in the skin, not merely perceptual reporting differences.
Distinct from screen dermatitis, not from EMF exposure per se. Johansson documented these biomarkers in individuals with EHS but his work does not prove that EMF directly caused them. The biomarker differences show that EHS subjects are biologically distinct from controls — but the causal pathway (whether prolonged EMF exposure caused the mast cell changes, or whether the mast cell profile predisposes to EHS, or whether a third factor drives both) remains an open research question.
Why blinded provocation studies don’t settle the EHS question: Critics of EHS point to studies showing EHS individuals cannot detect EMF above chance levels in blinded conditions. Johansson argues this is the wrong question. If EHS involves a chronic mast cell-mediated inflammatory response from cumulative exposure — rather than a real-time detection ability — then blinded provocation tests that expose subjects for 30 minutes don’t test the relevant biological mechanism. The biomarker findings support this alternative model.

The Johansson Work and Airways Research on EHS

The Johansson EHS biomarker research frames electromagnetic hypersensitivity as a real biological condition characterized by objective skin immune changes — not a purely psychosomatic response. This is directly relevant to the segment of Aires customers who identify as electrosensitive and report symptom relief from using the resonator. The Pall VGCC mechanism (elevated mast cell reactivity downstream of calcium channel activation) provides a mechanistic pathway from EMF exposure to the mast cell abnormalities Johansson documents. Read the broader EHS research overview →

EHS subjects show objective biological differences in their skin immune cells. This isn’t psychosomatic — it’s measurable.

Shop Aires Products →

Frequently Asked Questions

What did the Johansson 2006 research find about electromagnetic hypersensitivity?

Johansson found objective biological differences in skin biopsies from individuals reporting electromagnetic hypersensitivity (EHS) compared to controls: altered mast cell density and distribution, elevated histamine-releasing cells, and some nerve fiber changes. These findings suggest EHS is not purely psychosomatic — people who report it show measurable biological differences, regardless of whether those differences are caused by EMF exposure directly.

Is electromagnetic hypersensitivity a real medical condition?

WHO and most medical bodies recognize EHS as a real phenomenon in the sense that people genuinely experience the symptoms they report, but classify it as “idiopathic environmental intolerance attributed to electromagnetic fields” rather than a condition with a proven electromagnetic mechanism. Johansson’s work shows that EHS subjects have distinguishable biological profiles — which suggests either that EMF exposure causes the mast cell changes, or that individuals with this biological profile are more prone to report EHS, or that both are true.

Why can’t EHS individuals detect EMF in blinded tests?

Multiple blinded provocation studies have found that self-identified EHS individuals cannot reliably detect active vs. inactive EMF sources. Johansson argues that blinded tests for real-time detection miss the relevant mechanism: if EHS is driven by a chronic mast cell inflammatory response from cumulative exposure (rather than a real-time perception mechanism), a 30-minute blinded test is testing the wrong thing. The biomarker approach tests biology, not perception.

What are mast cells and why might they respond to EMF?

Mast cells are immune cells found in connective tissue including the skin, where they act as sentinels for physical and chemical stressors. When activated, they release histamine and other mediators that cause inflammation. In animal models, EMF exposure has been shown to stimulate mast cell degranulation (histamine release). The Pall VGCC framework provides a potential mechanism: calcium influx from VGCC activation activates mast cell degranulation pathways.

The EMF Landmark Research Series

→ Full series overview: The EMF Research You Need to Know

Etiquetas: Biomarkers, EHS, Electromagnetic Hypersensitivity, EMF Research, Johansson 2006, Landmark Studies, Mast Cells, Skin